The rapidly growing global burden of road-traffic accidents and fragility fractures makes research on fracture repair a vital component of the efforts needed to face this rising public health challenge. The focus on developing new and innovative strategies to treat fractures is easily justifiable given the potential human benefit from such discoveries. Randomized trials remain the standard to which the evaluation of novel fracture-healing therapies must continue to evolve. This article reviews randomized controlled trials in the context of the hierarchy of evidence, special challenges to their conduct in the setting of surgical research, and lessons learned from fracture-healing trials published to date. Suggestions are made regarding the optimal characteristics of fracture models and logistical consideration for ensuring the success of future trials. The realization that surgical trials have unique methodological and interpretative challenges has fueled a renewed vision of the design and execution of large, definitive clinical trials with a meaningful impact on the lives of patients.
Disclosure: The authors did not receive any outside funding or grants in support of their research for or preparation of this work. Neither they nor a member of their immediate families received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, division, center, clinical practice, or other charitable or nonprofit organization with which the authors, or a member of their immediate families, are affiliated or associated.
- Copyright © 2008 by The Journal of Bone and Joint Surgery, Incorporated
Enter your JBJS login information below.
Please note that your username is the email address you provided when you registered.